HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ZYBT

Zhengye Biotechnology Holding Ltd

Last Close
Jul 09 • 04:00PM ET
6.09
Dollar change
+0.06
Percentage change
1.00 		%
Healthcare • Drug Manufacturers - Specialty & Generic • China • NASD
Held by: PGJ
Scroll to Statements
Index- P/E182.88 EPS (ttm)0.03 Insider Own90.66% Shs Outstand47.17M Perf Week-1.30%
Market Cap288.61M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.43M Perf Month3.05%
Enterprise Value307.10M PEG- EPS next Q- Inst Own0.00% Short Float4.18% Perf Quarter58.18%
Income1.57M P/S11.15 EPS this Y- Inst Trans15.03% Short Ratio0.34 Perf Half Y-
Sales25.89M P/B7.38 EPS next Y- ROA2.27% Short Interest0.18M Perf YTD25.31%
Book/sh0.82 P/C104.95 EPS next 5Y- ROE4.06% 52W High14.30 -57.41% Perf Year-
Cash/sh0.06 P/FCF75.35 EPS past 3/5Y-36.18% - ROIC3.97% 52W Low3.50 74.00% Perf 3Y-
Dividend Est.- EV/EBITDA54.84 Sales past 3/5Y-7.94% - Gross Margin48.96% Volatility9.80% 18.47% Perf 5Y-
Dividend TTM- EV/Sales11.86 EPS Y/Y TTM-64.87% Oper. Margin8.80% ATR (14)1.22 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.80 Sales Y/Y TTM-13.57% Profit Margin6.06% RSI (14)44.59 Recom-
Dividend Gr. 3/5Y- - Current Ratio1.31 EPS Q/Q-79.39% SMA20-11.24% Beta- Target Price-
Payout- Debt/Eq0.30 Sales Q/Q-2.78% SMA50-26.63% Rel Volume0.07 Prev Close6.03
Employees277 LT Debt/Eq0.02 Earnings- SMA200-3.97% Avg Volume540.47K Price6.09
IPOJan 07, 2025 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume38,999 Change1.00%
Jul-03-25 08:30AM
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results
(PR Newswire)
May-23-25 04:05PM
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F
(GlobeNewswire) -12.33%
Jan-14-25 12:00PM
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option
(GlobeNewswire)
Jan-08-25 12:00PM
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
(GlobeNewswire) -7.41%
Jan-06-25 05:50PM
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering
(GlobeNewswire)
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.